Wright P W, Hargreaves R E, Bansal S C, Bernstein I D, Hellström K E
Proc Natl Acad Sci U S A. 1973 Sep;70(9):2539-43. doi: 10.1073/pnas.70.9.2539.
Serum factors present in rats rendered operationally tolerant to skin allografts by inoculation of allogeneic bone-marrow cells as newborns inhibit or "block" the cytotoxic effect of immune lymphocytes in vitro. These blocking factors were specifically removed from tolerant serum by absorption with allogeneic cells and later eluted from the absorbing cells in glycine buffer (pH 3.1). Blocking activity of the eluted material was resolved into fractions of low and higher molecular weight, which may be soluble histocompatibility antigen and specific alloantibody, respectively. Both antigen and antigen-antibody complexes may block in vitro, depending upon the assay used.
通过在新生时接种同种异体骨髓细胞而对皮肤同种异体移植产生手术耐受性的大鼠血清中存在的因子,在体外可抑制或“阻断”免疫淋巴细胞的细胞毒性作用。这些阻断因子通过用同种异体细胞吸收而从耐受血清中特异性去除,随后在甘氨酸缓冲液(pH 3.1)中从吸收细胞上洗脱下来。洗脱物质的阻断活性被分离为低分子量和高分子量部分,它们可能分别是可溶性组织相容性抗原和特异性同种异体抗体。根据所使用的检测方法,抗原和抗原 - 抗体复合物在体外均可产生阻断作用。